LogicBio Therapeutics, Inc. (LOGC): Price and Financial Metrics


LogicBio Therapeutics, Inc. (LOGC)

Today's Latest Price: $8.01 USD

0.17 (2.17%)

Updated Feb 14 12:00am

Add LOGC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

LOGC Daily Price Range
LOGC 52-Week Price Range

LOGC Stock Price Chart More Charts


LOGC Price/Volume Stats

Current price $8.01 52-week high $20.07
Prev. close $7.84 52-week low $6.34
Day low $7.72 Volume 52,600
Day high $8.17 Avg. volume 104,345
50-day MA $8.18 Dividend yield N/A
200-day MA $10.52 Market Cap 183.62M

LogicBio Therapeutics, Inc. (LOGC) Company Bio


LogicBio Therapeutics, Inc. is a genome editing company, which engages in developing medicines to treat rare diseases in patients with significant unmet medical need. It focuses on the commercialization of specific genome editing and integration of the therapeutic transgene. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Cambridge, MA.


LOGC Latest News Stream


Event/TimeNews Detail
Loading, please wait...

LOGC Latest Social Stream


Loading social stream, please wait...

View Full LOGC Social Stream

LOGC Price Returns

1-mo 3.89%
3-mo -10.10%
6-mo 0.50%
1-year -15.15%
3-year N/A
5-year N/A
YTD 11.25%
2019 -30.77%
2018 N/A
2017 N/A
2016 0.00%
2015 -80.77%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5316 seconds.